CA1201063A - Procede ameliore pour la preparation d'immuno- globulines igg purifiees - Google Patents

Procede ameliore pour la preparation d'immuno- globulines igg purifiees

Info

Publication number
CA1201063A
CA1201063A CA000407649A CA407649A CA1201063A CA 1201063 A CA1201063 A CA 1201063A CA 000407649 A CA000407649 A CA 000407649A CA 407649 A CA407649 A CA 407649A CA 1201063 A CA1201063 A CA 1201063A
Authority
CA
Canada
Prior art keywords
igg
deae
rich fraction
buffer
eluate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000407649A
Other languages
English (en)
Inventor
Albert D. Friesen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WINNIPEG RH INSTITUTE Inc (THE)
Original Assignee
WINNIPEG RH INSTITUTE Inc (THE)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WINNIPEG RH INSTITUTE Inc (THE) filed Critical WINNIPEG RH INSTITUTE Inc (THE)
Priority to CA000407649A priority Critical patent/CA1201063A/fr
Application granted granted Critical
Publication of CA1201063A publication Critical patent/CA1201063A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA000407649A 1982-07-20 1982-07-20 Procede ameliore pour la preparation d'immuno- globulines igg purifiees Expired CA1201063A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000407649A CA1201063A (fr) 1982-07-20 1982-07-20 Procede ameliore pour la preparation d'immuno- globulines igg purifiees

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000407649A CA1201063A (fr) 1982-07-20 1982-07-20 Procede ameliore pour la preparation d'immuno- globulines igg purifiees

Publications (1)

Publication Number Publication Date
CA1201063A true CA1201063A (fr) 1986-02-25

Family

ID=4123251

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000407649A Expired CA1201063A (fr) 1982-07-20 1982-07-20 Procede ameliore pour la preparation d'immuno- globulines igg purifiees

Country Status (1)

Country Link
CA (1) CA1201063A (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0270025A3 (en) * 1986-12-02 1989-05-10 Schwab & Co. Ges.M.B.H. Process for the preparation of an intravenously administrable immunoglobulin stable in the liquid phase
EP0268973A3 (fr) * 1986-11-27 1989-12-27 Biotest Pharma GmbH Procédé de production d'une préparation d'immunoglobuline G intraveineuse, stable et libre de virus
WO1998005686A1 (fr) * 1996-08-07 1998-02-12 Csl Limited Purification d'immunoglobulines
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
US6955917B2 (en) 1997-06-20 2005-10-18 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
US7847071B2 (en) 2003-02-28 2010-12-07 Lonza Biologics Plc. Antibody purification by protein a and ion exchange chromatography
EP2277915A1 (fr) 2004-02-27 2011-01-26 Octapharma AG Procédé de fabrication d'une préparation purifiée d'anticorps, exempte de virus.
WO2012080422A1 (fr) 2010-12-16 2012-06-21 Previpharma Ag Procédé de séparation, de concentration ou de purification d'une protéine de plasma (sanguin) ou d'un constituant viral d'un mélange
DE102010054767A1 (de) 2010-12-16 2012-06-21 Previpharma Ag Verfahren zur Trennung, Aufkonzentration und/oder Reinigung von (Blut)Plasmaprotein, Viren oder Virenbestandteilen

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0268973A3 (fr) * 1986-11-27 1989-12-27 Biotest Pharma GmbH Procédé de production d'une préparation d'immunoglobuline G intraveineuse, stable et libre de virus
US4880913A (en) * 1986-12-02 1989-11-14 Schwab & Co. Ges.M.B.H. Process for the preparation of an immunoglobulin which can be administered intravenously and is stable in liquid form
EP0270025A3 (en) * 1986-12-02 1989-05-10 Schwab & Co. Ges.M.B.H. Process for the preparation of an intravenously administrable immunoglobulin stable in the liquid phase
US6093324A (en) * 1996-08-07 2000-07-25 Csl Limited Purification of immunoglobulins
WO1998005686A1 (fr) * 1996-08-07 1998-02-12 Csl Limited Purification d'immunoglobulines
US6307028B1 (en) 1997-06-20 2001-10-23 Bayer Corporation Incorporated Chromatographic method for high yield purification and viral inactivation of antibodies
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
US6955917B2 (en) 1997-06-20 2005-10-18 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
USRE43655E1 (en) 1997-06-20 2012-09-11 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
USRE44558E1 (en) 1997-06-20 2013-10-22 Bayer Healthcare Llc Chromatographic method for high yield purification and viral inactivation of antibodies
US7847071B2 (en) 2003-02-28 2010-12-07 Lonza Biologics Plc. Antibody purification by protein a and ion exchange chromatography
EP2277915A1 (fr) 2004-02-27 2011-01-26 Octapharma AG Procédé de fabrication d'une préparation purifiée d'anticorps, exempte de virus.
WO2012080422A1 (fr) 2010-12-16 2012-06-21 Previpharma Ag Procédé de séparation, de concentration ou de purification d'une protéine de plasma (sanguin) ou d'un constituant viral d'un mélange
DE102010054766A1 (de) 2010-12-16 2012-06-21 Previpharma Ag Verfahren zur Trennung, Aufkonzentration oder Reinigung eines (Blut)Plasmaproteins oder Virenbestandteils aus einer Mischung
DE102010054767A1 (de) 2010-12-16 2012-06-21 Previpharma Ag Verfahren zur Trennung, Aufkonzentration und/oder Reinigung von (Blut)Plasmaprotein, Viren oder Virenbestandteilen

Similar Documents

Publication Publication Date Title
US6093324A (en) Purification of immunoglobulins
JP4445202B2 (ja) 治療的使用のためのヒト免疫グロブリン濃縮物の調製方法
US10919930B2 (en) Enhanced purification of antibodies and antibody fragments by apatite chromatography
US6069236A (en) Immunoglobulin G concentrate for therapeutic use and process for producing said concentrate
US5118796A (en) Efficient large-scale purification of immunoglobulins and derivatives
AU749336B2 (en) Chromatographic method for high yield purification and viral inactivation of antibodies
US4673734A (en) Porous mineral support coated with an aminated polysaccharide polymer
EP2831096B1 (fr) Matrice de chromatographie par affinité
US5164487A (en) Manufacturing intravenous tolerable immunoglobulin-g preparation
AU684202B2 (en) Low temperature albumin fractionation using sodium caprylate as a partitioning agent
US6835379B2 (en) Method of producing IgG
US20120149875A1 (en) Affinity chromatography matrix
HU217850B (hu) Eljárás antitest tisztítására
US4138287A (en) Purifying and isolating method for hepatitis virus to use in preparing vaccine
CA1201063A (fr) Procede ameliore pour la preparation d'immuno- globulines igg purifiees
US5346992A (en) Process for isolating human albumin from supernatant IV, in particular IV-4, or from COHN's fraction V or from an analogous supernatant or fraction
EP4108673A1 (fr) Procédé de purification sans protéine a d'adalimumab
JP4250769B2 (ja) 高度に精製されたｖＷＦまたは因子ＶＩＩＩ／ｖＷＦ複合体を得る方法
IE80638B1 (en) Monoclonal antibodies to new factor VIII coagulant polypeptides
JPH0533239B2 (fr)
CN104507954A (zh) 磨光白蛋白的方法
US4806346A (en) Method for isolation of antigen specific immunoglobulin
US11884702B2 (en) Systems and methods for process scale isolation of immunoglobulin G
Wichman et al. Purification of human immunoglobulin M by affinity chromatography on protamine-Sepharose
CA1168152A (fr) Procede de preparation de fractions de plasma humain contenant des immunoglobulines

Legal Events

Date Code Title Description
MKEX Expiry
MKEX Expiry

Effective date: 20030225